SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Maul Coin

Maul Coin is generating buzz as a community-driven project aiming to replicate the massive growth of previous viral memecoins through active social media raiding and a transparent developer-led approach. While the community is currently focused on overcoming technical hurdles like securing official charts and listings, members are heavily incentivized by the potential for 1000x gains and a movement-based ethos that rejects typical 'pump and dump' behavior.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cash is attracting significant community attention as traders debate its potential for a breakout, with many highlighting the upcoming Layla upgrade in May 2026 as a pivotal catalyst for increased utility and quantum resistance. While bulls point to resilient price action and the network's low-fee, peer-to-peer focus, ongoing discussions remain polarized between those expecting a major decoupling from Bitcoin and critics dismissing the asset due to historical performance concerns.

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Bristol-Myers Squibb Co.

Bristol-Myers Squibb is seeing increased investor attention as the company leverages a robust pipeline, including recent label expansions and the continued development of its oncology portfolio, to navigate patent cliffs. Market sentiment is bolstered by steady dividends and strategic collaborations, though traders remain focused on upcoming trial data readouts that will be critical for long-term growth and potential M&A activity.

Nucor Corp. engages in the manufacture of steel products, and ferrous and non-ferrous materials. It operates through the following segments: Steel Mills, Steel Products, and Raw Materials. The Steel Mills segment consists of producing sheet, plate, structural, and bar steel. The Steel Products segment includes steel joists and joist girders, deck, fabricated concrete reinforcing, cold finished, fasteners, metal building systems, grating, tubular, piling products businesses, and wire mesh. The Raw Materials segment consists of direct reduced iron, and ferrous and nonferrous metals. The company was founded by Ransom E. Olds in 1905 and is headquartered in Charlotte, NC.

Nucor Corp.

Nucor is trending as investors react to the anticipated formalization of 25% tariffs on global steel and aluminum imports. The community is actively discussing how these protective measures may bolster domestic manufacturing demand and pricing power, with some participants expressing caution regarding potential inflationary impacts and global trade volatility.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is seeing renewed market interest driven by recent leadership changes, institutional moves toward the U.S. market, and its focus on quantum-resistant infrastructure. The community is actively debating its long-term potential as a Layer-1 solution, with many traders closely monitoring technical indicators and price consolidation for signs of a sustained breakout.

Invesco DB US Dollar Index Bullish Fund - Common units of beneficial interest

Invesco DB US Dollar Index Bullish Fund

The Invesco DB US Dollar Index Bullish Fund is currently trending as markets weigh escalating trade tensions and geopolitical uncertainty against conflicting labor data and shifting Federal Reserve rate expectations. Investors are actively debating the dollar's role as a safe-haven asset amidst potential policy realignments, currency intervention risks, and ongoing debates over U.S. fiscal deficits and de-dollarization.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is trending due to heightened investor focus on the upcoming PDUFA decision date for RP1, with market participants debating whether the resubmission successfully addresses previous FDA concerns or if a second Complete Response Letter is likely. The community remains deeply divided, with some traders citing unusual options volume and potential short-covering as bullish indicators, while skeptics warn of significant downside risk if the company fails to secure accelerated approval.

What Is Tezos (XTZ)?   Tezos is a high-performing blockchain and open-source platform for assets and applications, with a strong focus on code security, on-chain governance, and decentralization. Tezos 2.0, the upcoming step in the evolution of Tezos, aims to improve scalability (via layer 2s), composability, and to implement support to mainstream programming languages (like Javascript, Typescript, Python, and many others).   Initially built with formal verification in mind, the Tezos protocol enables builders to avoid bugs when developing smart contracts, making it particularly suited to applications that require a high degree of security and certainty.   Tezos’ LPoS (Liquid Proof-of-Stake) consensus mechanism enables any stakeholder to take part, directly or by delegation, in the consensus process, and to be rewarded for securing the network. Rather uniquely, Tezos’ on-chain governance system also enables stakeholders to create and vote on protocol upgrade proposals. This pioneering system allows the protocol to self-amend and upgrade itself without leading to a split (or fork) in the blockchain, empowering the community without slowing down innovation.   First proposed in 2014 and launched in 2018, the Tezos Mainnet has a proven track record of running uninterrupted ever since, having earned a strong reputation for technical excellence and a supportive community.    Who Are the Founders of Tezos? Tezos was conceived by Arthur and Kathleen Breitman in a 2014 white paper under the pseudonym L.M. Goodman in a nod to Satoshi Nakamoto, referencing a journalist who had misidentified the creator of Bitcoin.   In a previous paper, the Breitmans had argued that Bitcoin's biggest shortcomings were the lack of a governance process that invited contributions from its community of users, cost and centralization issues raised by its proof-of-work system, the limited expressiveness of its programming language which didn’t allow for smart contracts, and security

Tezos

Tezos is currently generating intense debate among retail traders, with many participants expressing extreme bearish sentiment and anticipation of further downward price movement. The community remains deeply divided, with vocal skeptics labeling the project a "ghost chain" while contrarian traders continue to monitor support levels in search of potential re-entry points.

iShares Trust - iShares Russell 2000 Value ETF

iShares Russell 2000 Value ETF

The iShares Russell 2000 Value ETF (IWN) is trending as investors monitor ongoing Federal Reserve policy debates and geopolitical volatility, with many community members focusing on the index as a bellwether for small-cap performance. Traders are actively discussing the potential for a rotation into value-oriented small-cap equities, frequently using IWN and the Russell 2000 to gauge market breadth and position against broader index trends.

Oscar Health, Inc. is a healthcare insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is capturing significant investor attention as markets weigh the company's ambitious 2026 profitability guidance against its recent quarterly earnings miss. While the community remains deeply divided between those betting on long-term growth through AI-driven operational efficiency and skeptics concerned about medical loss ratios, retail traders are closely tracking the stock's volatility ahead of potential structural pivots in the healthcare sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The Fundrise Innovation Fund (VCX) Participates in OpenAI's $122 Billion Funding Round

The Fundrise Innovation Fund (VCX) today announced its participation in OpenAI's latest funding round, increasing its existing position in one of the world's most consequential technology companies...

<ul class="summary-bullets"><li>OpenAI on Tuesday announced that it raised $122 billion in equity financing – the largest investment round for any company.</li><li>The financing and stake sale of individual investors comes ahead of a potential initial public offerings, expected towards the end of the year.</li><li>Investors are increasingly eying exposure to marquee pre-IPO tech companies such as SpaceX and Anthropic, investing into funds that own them.</li></ul>Noted tech investor Cathie Wood has poured in $240 million as part of OpenAI’s mammoth $122 billion funding round – a significant development that opens the door for retail investors to gain exposure to the world’s leading AI company, which is also gearing up for an initial public offering.The investment is made from her three exchange traded funds ARK Innovation (ARKK), ARK Fintech Innovation (ARKF) and ARK Next Generation Internet (ARKW), according to ARK Invest disclosures.&nbsp;As a percentage of their total holdings, the OpenAI stake accounts for 3.1% for ARKK, and 3.0% for ARKW and ARKF. Wood had earlier invested a similar amount in OpenAI through her venture fund, the ARK Venture Fund.Separately, OpenAI said it secured over $3 billion investment as part of the round from individual investors – a first for the company.&nbsp;OpenAI is “broadening ownership and giving more people the opportunity to share in the upside economics of OpenAI and the AI era,” it said in the&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://openai.com/index/accelerating-the-next-phase-ai/">blog post</a> announcing its fundraise on Tuesday.Although the ARK ETFs have declined in the recent months, with ARK Innovation ETF (ARKK) logged its worst quarter since early 2025, the OpenAI stake might increase their appeal.Investors are increasingly seeking exposure to marquee pre-IPO tech companies such as&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/how-to-buy-spacex-before-ipo-5-funds-owning-spacex/cZ3uVbqRIlL">SpaceX</a> and&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/anthropic-s-ipo-said-to-be-coming-as-early-as-october-here-s-how-to-pick-up-a-stake-before-it-goes-public/cZ3uU4aRIlA">Anthropic</a>, and are investing in funds that own them, Stocktwits has reported.&nbsp;Besides the ARK ETFs, KraneShares Artificial Intelligence &amp; Technology ETF (AGIX), Fundrise Innovation Fund (VCX), and Destiny Tech100 (DXYZ) are some of the funds that have seen significant interest among retail traders on Stocktwits of late.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nike-stock-tumbles-toward-9-year-low-retail-traders-shrug-off-soft-outlook/cZ7HhpHRInK">Nike Stock Tumbles Toward 9-Year Low: Retail Traders Shrug Off Soft Outlook To Scoop Up ‘Crazy Good Pricing’</a>

Cathie Wood, CEO & Chief Investment Officer of ARK Invest, speaks onstage during Day 2 of 2023 Invest Fest at Georgia World Congress Center on August 27, 2023 in Atlanta, Georgia. (Photo by Paras Griffin/Getty Images)

Cathie Wood Makes $240M Bet In OpenAI's Mammoth Fundraise As IPO Looms

OpenAI said it is broadening access to its equity to public investors through the ARK ETFs – and also separately raised $3 billion from individual investors.

Equity

OpenAI said it is broadening access to its equity to public investors through the ARK ETFs – and also separately raised $3 billion from individual investors.


<ul class="summary-bullets"><li>TechCrunch reported, citing Indagari data, that Claude’s popularity has increased significantly over the last six months.</li><li>Reports said that Anthropic, OpenAI, and others are working on AI models that would be proficient in hacking.</li><li>Meanwhile, funds like KraneShares AI ETF, ARK Venture Fund (3.8%) and Fundrise Innovation Fund are gaining traction from retail investors for their stakes in top unlisted tech giants.</li></ul>With Anthropic eyeing an initial public offering as early as October, investors are increasingly looking for exposure to the fast-growing AI startup while closely tracking developments that could shape sentiment ahead of the listing.New data, first&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://techcrunch.com/2026/03/28/anthropics-claude-popularity-with-paying-consumers-is-skyrocketing/">reported</a> by TechCrunch, indicates that the Anthropic AI bot Claude gained paid subscribers at record levels.&nbsp;Consumer spending tracker Indagari analyzed anonymized credit card transactions from 28 million U.S. consumers and estimated that paid users for Clause, excluding enterprise users, more than doubled to nearly 600,000 from 250,000 through February.&nbsp;The TechCrunch attributed the bot’s surge in popularity to the ongoing clash between the U.S. government and Anthropic over defense-related AI use, as well as the company’s recent Super Bowl ads that&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://techcrunch.com/2026/02/13/anthropics-super-bowl-ads-mocking-ai-with-ads-helped-push-claudes-app-into-the-top-10/">took aim</a> at rival OpenAI’s ChatGPT.In separate but crucial news for the AI sector, Axios&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.axios.com/2026/03/29/claude-mythos-anthropic-cyberattack-ai-agents">reported</a>, citing AI and government officials, that Anthropic, OpenAI and other tech giants will soon release new models that could hack sophisticated systems at scale.&nbsp;In fact, last week, Fortune&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://fortune.com/2026/03/26/anthropic-says-testing-mythos-powerful-new-ai-model-after-data-leak-reveals-its-existence-step-change-in-capabilities/?utm_source=newsletter&amp;utm_medium=email&amp;utm_campaign=sendto_newslettertest_csuite&amp;stream=top#_ga=2.267172493.2012405429.1774863814-1431982654.1771288787">reported</a> on an unpublished Anthropic blog post describing Mythos. The post said the model is "currently far ahead of any other AI model in cyber capabilities."As the potential IPO draws closer, investors are increasingly eyeing proxy funds that offer exposure to Anthropic. Stocktwits published an&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/anthropic-s-ipo-said-to-be-coming-as-early-as-october-here-s-how-to-pick-up-a-stake-before-it-goes-public/cZ3uU4aRIlA">explainer</a> on them last week.Only two ETFs –&nbsp;<a href="https://stocktwits.com/symbol/AGIX">KraneShares Artificial Intelligence &amp; Technology ETF (AGIX)</a> and&nbsp;<a href="https://stocktwits.com/symbol/DXYZ">Destiny Tech 100 (DXYZ)</a> – currently offer direct exposure to Anthropic, though allocations are relatively small and not fully disclosed.Retail-access private funds provide more meaningful exposure, with&nbsp;<a href="https://stocktwits.com/symbol/ARKVX">ARK Venture Fund (ARKVX)</a> (3.8%) and&nbsp;<a href="https://stocktwits.com/symbol/VCX">Fundrise Innovation Fund (VCX)</a> (20%) holding notable stakes in Anthropic.On Stocktwits, the retail sentiment was ‘bullish’ for AGIX and ‘extremely bullish’ for DXYZ, VCX and ARKVX. The sentiment for&nbsp;<a href="https://stocktwits.com/symbol/ANTHROPIC">Anthropic</a> was ‘neutral.’&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/rzlv-jumps-13-ahead-of-half-year-report-analysts-expect-huge-upside-potential-this-year/cZERl20RIZF">RZLV Jumps 13% Ahead Of Half Year Report – Analysts Expect Huge Upside Potential This Year</a>&nbsp;

The Claude by Anthropic app logo appears on the screen of a smartphone

Anthropic’s Paid Users Reportedly Doubled Ahead Of IPO – Retail Piles Into Proxy Funds

Retail investors are increasingly eyeing exchange-traded and private funds that offer exposure to Anthropic ahead of its potential IPO in the fourth quarter.

<ul class="summary-bullets"><li>The fund launched a tokenized on-chain version of its portfolio, offering global exposure to SpaceX, OpenAI, Anthropic and Databricks through a single asset.</li><li>CEO Ben Miller said Fundrise rejected hedge fund allocations, prioritizing retail investors for access to shares during the listing.</li><li>Demand for proxy exposure is rising ahead of expected SpaceX, Anthropic and OpenAI IPOs, even as Citron questioned the fund’s premium to NAV.</li></ul>Shares of Fundrise Innovation Fund (VCX) fell nearly 10% in premarket trading on Tuesday, giving back some recent gains as the fund expanded blockchain-based access to private tech giants, including SpaceX and Anthropic.The decline follows a volatile stretch since the fund’s listing, during which shares surged more than 500% over five sessions before dropping over 65% after short seller Citron Research disclosed a bearish position.The heightened buzz for&nbsp;<a href="https://stocktwits.com/symbol/VCX">VCX</a> comes as investors increasingly position through public-market proxy vehicles ahead of expected listings from several large private tech companies widely seen as anchors of the next major IPO cycle.<h2 class="st-heading-2">VCX Takes Private Tech Onchain</h2>The retail-focused structure now extends beyond the public listing through a newly tokenized version of the portfolio that enables eligible investors globally to gain exposure to a diversified basket of late-stage private tech companies, including SpaceX, OpenAI, Anthropic and Databricks, through a single blockchain-based asset.Payward, the parent company of the tokenized equities platform enabling the launch, said the move expands access beyond traditional venture structures. The tokenized version is expected to go live in the coming days and will allow integration into on-chain financial applications, including lending, collateralization, and automated investment strategies.<h2 class="st-heading-2">VCX Rejects Hedge Funds For Retail</h2>In a new&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.youtube.com/watch?v=inqOrylHwp8&amp;t=5s">interview</a> over the weekend with Craig Stephens, host of the Access IPOs podcast, Fundrise CEO Ben Miller said the fund was structured to prioritize individual investors rather than institutional buyers typically involved in IPO allocations. Miller said the firm rejected raising capital through hedge funds and instead distributed shares directly to platform investors.“Let the retail investors be the ones who get the inside shares rather than the hedge funds,” Miller said, adding that “our customer is the retail investor, is the individual investor, not the institutions.”VCX has raised between $450 million and $500 million from about 100,000 investors, according to Miller, and delivered strong early performance before its listing. “It performed really well over the first few years,” he said. “I think the average client return was 40% a year.”<h2 class="st-heading-2">Private Tech IPO Pipeline Heats Up</h2>Demand for vehicles offering proxy exposure to private technology leaders has increased following reports that SpaceX could file its IPO prospectus any day now, ahead of a potential June listing expected to raise more than $75 billion.Anthropic has hired IPO counsel ahead of a possible 2026 listing, while OpenAI is reportedly preparing for a potential fourth-quarter debut after expanding a financing round that could mark its final major private raise before entering public markets. Together, the three companies represent more than $2 trillion in combined private-market value.<h2 class="st-heading-2">Citron Short Sparks VCX Valuation Debate</h2>The rally has also drawn scrutiny from short seller Citron Research, which&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/vcx-tanks-after-citron-shorts-anthropic-proxy-urges-sec-investigation-fundrise/cZ3rU6ORIkP">said</a> it is short VCX and argued that the fund’s market price remains disconnected from the underlying asset's value. Citron noted that the shares traded above $400, even though the underlying assets were worth roughly $19, and urged regulators to examine whether the sponsor is compensating influencers or publishers to promote the fund.However, Fundrise rejected the criticism. “Some companies short stock and then do PR smear campaign to drive the stock down,” Miller&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/vcx-ceo-pushes-back-against-citron-criticism-says-retail-investors-risk-missing-out-on-private-ai-wealth/cZ3HcpwRIly">said</a> on CNBC. “Trying to talk down the stock, that hurt our investors.”<h2 class="st-heading-2">How Do Stocktwits Users Feel About VCX?</h2>On Stocktwits, retail sentiment for VCX has remained ‘extremely bullish’ over the past week amid ‘extremely high’ message volume,&nbsp;with a more than quadrupling of followers over the past week.<figure class="image"><img src="https://news.stocktwits-cdn.com/vcx_ss_png_7a93969e28.webp" alt="vcx ss.png" width="970" height="144"><figcaption>VCX sentiment and message volume as of March 30 | Source: Stocktwits</figcaption></figure>One user&nbsp;<a href="https://stocktwits.com/chamono1942/message/648878128">said</a>, “This is a combination of well-known unlisted stocks and cryptocurrencies! Game changers of the future!”<stembedurl>https://stocktwits.com/chamono1942/message/648878128</stembedurl>Another user&nbsp;<a href="https://stocktwits.com/toolajittooquit/message/648901340">said</a>, “Just waiting on the spacex ipo to watch vcx jump to $500.”<stembedurl>https://stocktwits.com/toolajittooquit/message/648901340</stembedurl>For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/mark-cuban-roasts-elon-musk-work-will-be-optional-spacex-ipo-grok/cZER14cRIZ1">Will SpaceX IPO Prospectus Be Written By Grok? Mark Cuban Roasts Elon Musk Over His ‘Work Will Be Optional’ Claim</a>

VCX Tumbles Premarket: Fundrise Opens SpaceX, Anthropic, Databricks Onchain After Snubbing Hedge Funds

Payward-backed infrastructure enables the tokenized version to integrate into lending, collateralization and automated on-chain investment strategies.

<ul class="summary-bullets"><li>Miller said short sellers are spreading negative narratives to pressure the stock.</li><li>He reiterated that Fundrise is focused on opening private market opportunities traditionally reserved for the wealthy.</li><li>On Thursday, Citron raised regulatory concerns tied to past SEC charges.</li></ul>Fundrise Innovation Fund (VCX) co-founder and CEO Ben Miller on Friday pushed back against short-seller criticism, defending both his firm’s strategy and its broader mission to expand access to venture capital investing.&nbsp;His remarks come after&nbsp;Citron Research on Thursday said it is&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/vcx-tanks-after-citron-shorts-anthropic-proxy-urges-sec-investigation-fundrise/cZ3rU6ORIkP">short</a> the public venture fund. The short seller said Fundrise Advisors LLC faced SEC charges in 2023 over paid solicitation practices and urged regulators to examine whether the firm is currently compensating influencers or publishers to promote VCX.&nbsp;<h2 class="st-heading-2">CEO Defends Strategy Against Short Seller Claims</h2>On CNBC, Miller addressed concerns about the stock and the fund, stating that critics are overlooking the fund's long-term vision of opening private markets to everyday investors.&nbsp;<blockquote>“Some companies short stock and then do pr smear campaign to drive the stock down. Making up nonsense, throwing mud against the wall. That is totally relevant. But trying to talk down the stock, that hurt our investors.”-Ben Miller, Co-founder and CEO, Fundrise Innovation Fund</blockquote>He added that many of the most valuable technology companies are remaining private for longer periods, limiting wealth creation opportunities for typical investors. By offering exposure earlier in a company’s lifecycle, Fundrise aims to shift that dynamic.<a href="https://stocktwits.com/symbol/VCX">Fundrise Innovation Fund stock</a> traded over 24% lower in Friday’s premarket. On Stocktwits, retail sentiment around the stock remained in ‘extremely bullish’ territory amid ‘extremely high’ message volume levels.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_03_27_074145_png_dd26ceecaf.webp" alt="VCX’s Sentiment Meter and Message Volume as of 07:00 a.m. ET on Mar. 27, 2026 | Source: Stocktwits" width="930" height="97"><figcaption>VCX’s Sentiment Meter and Message Volume as of 07:00 a.m. ET on Mar. 27, 2026 | Source: Stocktwits</figcaption></figure>In a post on X, Citron rejected CEO Ben Miller’s claims of a “PR smear campaign,” adding that its criticism is grounded in simple financial logic.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_03_27_075030_png_1890646aea.webp" alt="Screenshot 2026-03-27 075030.png" width="744" height="179"></figure><h2 class="st-heading-2">Building A New Investment Model</h2>According to Miller, Fundrise began working with regulators in 2021 to establish a structure that would allow retail investors to participate in venture capital opportunities. The effort culminated in the launch of a venture fund in 2022, with a notably low entry threshold. Since then, the platform has attracted a large base of U.S. investors.Looking ahead, Miller expressed confidence that venture capital could become a standard component of diversified portfolios, similar to real estate. He pointed to rapid advancements in AI as a key driver, warning that if breakthroughs such as artificial general intelligence occur before leading firms go public, much of the resulting value could remain concentrated among a small group of private investors.VCX stock has gained 634% year to date.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/ccl-stock-slips-premarket-ahead-of-q1-earnings/cZ3uyrGRIlr">Carnival Stock Slips Premarket Ahead Of Q1 Earnings: Analyst Expects Solid Performance Despite Higher Fuel Costs</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The candlestick chart of the cryptocurrency Terra Luna with the sell-off.

VCX CEO Pushes Back Against Citron Criticism – Says Retail Investors Risk Missing Out On Private AI Wealth 

CEO Miller responded to concerns about the stock and the fund, noting that detractors are missing the broader goal of making private-market opportunities accessible to everyday investors.

<ul class="summary-bullets"><li>Started in 2021,&nbsp;Anthropic was last valued at $380 billion.</li><li>Reports say the AI firm is targeting a $60 billion raise, with the offering expected in October.</li><li>ETFs such as KraneShares Artificial Intelligence &amp; Technology ETF (AGIX) and Destiny Tech100 (DXYZ) hold Anthropic equity.</li></ul>AI upstart Anthropic is moving decisively toward a public listing, with a new report suggesting it has already held talks with investment banks and could launch its IPO as early as October. The offering is shaping up to be part of a mega wave of listings this year that is also expected to include OpenAI and SpaceX.Even before prospectuses are filed, some investors are getting ahead of the curve by gaining exposure through exchange-traded funds and private investment vehicles, products that have attracted significant interest over the past year.Bloomberg <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2026-03-27/claude-ai-maker-anthropic-said-to-weigh-ipo-as-soon-as-october">reported</a>, citing sources, that Goldman Sachs, JPMorgan, and Morgan Stanley might be hired managers for Anthropic's IPO, which could raise a staggering $60 billion.Anthropic, founded by former OpenAI employees in 2021, is believed to be <a href="https://stocktwits.com/news-articles/markets/equity/why-anthropic-s-ipo-might-just-be-juicier-than-open-ai-s/cLIXYLXRE1c">quickly closing the gap</a> with OpenAI. According to reported internal projections, Anthropic expects to be profitable in 2028, while OpenAI expects $74 billion in operating losses that year.Anthropic has also left a mark more recently with the launch of a series of agentic AI tools as part of its offering, Claude Cowork, which triggered <a href="https://stocktwits.com/news-articles/markets/equity/saas-stocks-stumble-as-ai-fears-trigger-selloff-retail-eyes-selective-bets/cmUu4hVR49H">a widespread sell-off</a> in the shares of major software companies.Although the IPO timeline could vary, picking up exposure to Anthropic before the event is possible through the following funds:<figure class="table"><table class="ck-table-resized"><colgroup><col><col><col></colgroup><tbody><tr><td>Fund</td><td>Anthropic Exposure</td><td>Top 5 Holdings</td></tr><tr><td>KraneShares Artificial Intelligence &amp; Technology ETF (AGIX)</td><td>2.5%</td><td>Nvidia (5.1%), Microsoft (4%), Meta (3.9%), Alphabet (3.5%), Apple (3.3%)</td></tr><tr><td>Fundrise Innovation Fund (VCX)</td><td>20%</td><td>Databricks (17.7%), OpenAI (9.9%), Anduril (6.9%), Ramp (5.1%), Tesla (5%)</td></tr><tr><td>ARK Venture Fund (ARKVX)</td><td>3.8%</td><td>SpaceX (17.9%), Replit (4.9%), Figure AI (3.7%), Databricks (3.1%), Zipline (3%)</td></tr><tr><td>Destiny Tech100 (DXYZ)</td><td>Undisclosed</td><td>SpaceX (16.2%), Shield AI (4.1%), Databricks (4%), Beast Industries (3.5%), OpenEvidence (3.5%)</td></tr></tbody></table></figure>Source: Funds’ disclosures.<h2 class="st-heading-2"> Soaring Interest In Private Tech ETFs, Funds</h2>For now, only two exchange-traded funds – the KraneShares Artificial Intelligence &amp; Technology ETF (AGIX) and Destiny Tech100 (DXYZ) – offer direct exposure to Anthropic.About 2.5% of AGIX's holdings is currently Anthropic equity, while DXYZ’s Anthropic holding is much smaller and&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://destiny.xyz/tech100">not detailed</a> by the fund.&nbsp;ARK Venture Fund (ARKVX), a private fund that allows retail access, is another major source. About 3.8% of ARKVX’s portfolio is composed of Anthropic equity, in addition to large stakes in SpaceX, OpenAI, and several listed tech companies.Meanwhile, the Fundrise Innovation Fund (VCX), another private fund with retail access, held roughly 20% exposure to Anthropic.The funds are in high demand. Shares of the VCX have surged nearly 2,000% since listing last week, a key signal to investors in pre-IPO tech companies. ARKVX has returned 63% over the past year, sharply higher than the benchmark indices; DXYZ shares have declined 26% over the past 12 months.The funds are already a hit with retail investors. Watchers on Stocktwits for VCX have increased 2,000% in a week, while those for DXYZ and ARKVX have increased 32% and 22%, respectively, over the past month.Besides the funds, Amazon and Alphabet are among the largest investors with multi-billion-dollar stakes in Anthropic.<h2 class="st-heading-2">Anthropic Valuation Soars To $380B</h2>Anthropic was valued at about $380 billion following a $30 billion funding round led by MGX that closed in February. The company counts Alphabet, Google, Amazon, Microsoft, and Nvidia among its partners, each of which has also taken an equity stake and supplied specialized chips and other technology under agreements worth tens of billions of dollars.It’s been in the news recently over its fallout with the Pentagon over the use of AI in the defense business.&nbsp;The U.S. government designated the AI firm a supply chain risk – meaning it can’t do business with the government or any of its contractors – after Anthropic refused to remove safety guardrails that prevent its Claude AI from being used for fully autonomous weapons or mass domestic surveillance.On Thursday, Anthropic won a preliminary injunction, pausing the government’s plan to sever all ties with the company while the case is heard in the San Francisco federal court.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nvidia-s-tough-year-gets-slightly-worse-indie-game-devs-call-for-boycott-urge-peers-to-tank-stock-here-s-why/cZ3utfIRIlN">Nvidia's Tough Year Gets Slightly Worse: Indie Game Devs Call For Boycott, Urge Peers To 'Tank' Stock — Here's Why</a>&nbsp;

This photograph shows a smartphone screen displaying the logo of Anthropic, an American company specializing in artificial intelligence (AI). (Photo by Samuel Boivin/NurPhoto via Getty Images)

Anthropic's IPO Said To Be Coming As Early As October — Here's How To Pick Up A Stake Before It Goes Public

Anthropic is billed as one of the biggest forthcoming IPOs this year.

The Databricks logo appears on the screen of a smartphone in Reno, United States, on December 7, 2024. (Photo by Jaque Silva/NurPhoto via Getty Images)

Robinhood Ventures Fund Eyes Best Week Since Listing: Retail Traders Chase Pre-IPO Exposure To Snowflake Rival

Databricks raised $4 billion at a $134 billion valuation in December and launched its LakeWatch cybersecurity platform this week.

RVI Fund Eyes Best Week Ever — Retail Chases Databricks Pre-IPO Exposure

In this photo illustration, the logo of SpaceX is displayed on a smartphone screen.

Want In On SpaceX Before The IPO? Here Are 5 Funds That Already Own It

Investors are increasingly turning to a handful of listed funds that already hold stakes in SpaceX as one of the few ways to gain exposure before the company begins trading publicly.

<ul class="summary-bullets"><li>The short seller urged the SEC’s Division of Enforcement to investigate whether Fundrise is currently paying influencers, YouTube creators, newsletters, or any content publishers to promote VCX.</li><li>Citron also questioned whether Fundrise’s domain for VCX, GetVCX.com, constitutes a misleading solicitation of a publicly traded security, since it is a call to action in itself.</li><li>It noted that the Fundrise Innovation Fund has disclosed marketing expenses in its prospectus, and called for scrutiny into how those funds are actually being used.</li></ul>Fundrise Innovation Fund (VCX) tanked more than 37% in Thursday’s opening trade after Citron Research on Thursday announced that it is short the public venture fund that provides investors with access to top private technology companies.The short seller highlighted in a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/CitronResearch/status/2037156632518398163">post</a> on X that VCX is currently trading at more than $400, even though its assets are worth $19.Citron noted that the fund’s sponsor, Fundrise Advisors LLC, was charged by the U.S. Securities and Exchange Commission (SEC) in 2023 for violations related to paid solicitation.Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/VCX">Fundrise Innovation Fund</a> trended in the ‘extremely bullish’ territory at the time of writing.<h2 class="st-heading-2">Citron Calls For SEC Investigation</h2>The short seller urged the SEC’s Division of Enforcement to investigate whether Fundrise is currently paying influencers, YouTube creators, newsletters or any content publishers to promote VCX.Citron also questioned whether Fundrise’s domain for VCX, GetVCX.com, constitutes a misleading solicitation of a publicly traded security since it is a call to action in itself.Citron noted that the Fundrise Innovation Fund has disclosed marketing expenses in its prospectus, and called for scrutiny into how those funds are actually being used.“Retail investors chasing Anthropic and SpaceX exposure deserve answers. With this sponsor, these are not paranoid questions. There are too many of these guys,” Citron stated.VCX’s top holding is Anthropic at 20.7%, followed by Databricks at 17.7% and OpenAI at 9.9%, according to data from Fundrise’s website.<h2 class="st-heading-2">Fundrise Innovation Fund Story Mirrors DXYZ, Says Citron</h2>Citron added that the Fundrise Innovation Fund story mirrors that of Destiny Tech100 (DXYZ), which also gives investors access to private AI and tech companies such as SpaceX, xAI, OpenAI, and Databricks.Citron noted that at its March 2024 debut, retail frenzy pushed DXYZ above $75 apiece despite a net asset value (NAV) of $5, implying a premium of more than 1,400%.DXYZ is currently hovering around $30 per share, and its NAV stood at $19.97 as of Dec. 31, 2025, implying a premium of about 50%.“If $VCX premium compresses to where $DXYZ trades today, here is the math:&nbsp; NAV: ~$19 DXYZ current premium: ~35% Implied $VCX price: ~$26. That is a decline of over 93% from current levels,” said Citron.<h2 class="st-heading-2">How Did Retail Traders React?</h2>One user thinks DXYZ is a better, less risky trade than VCX, adding that it has “plenty of room to run.”<stembedurl>https://stocktwits.com/PoweringTheFuture/message/648619622</stembedurl>Another user echoed similar sentiments, stating that people should be buying DXYZ.<stembedurl>https://stocktwits.com/creativeflood/message/648618869</stembedurl><a href="https://stocktwits.com/symbol/VCX">VCX stock</a> is up 1,116% year-to-date.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/applovin-market-lead-intact-despite-competition-piper-sandler-app-stock/cZ3rUhKRIkT">AppLovin Market Lead Intact Despite AI Disruption Risks, Says Piper Sandler</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Trading digital board showing the data on global stock market crash. | Image source: Getty Images

Citron Shorts VCX, Calls On SEC To Investigate If Fundrise Is Paying Influencers To Promote The Fund

Citron noted that the fund’s sponsor, Fundrise Advisors LLC, was charged by the U.S. Securities and Exchange Commission in 2023 for violations related to paid solicitation.

The Nevada-based mining company said that it has filed a third-party, independent Technical Report updating its Mineral Resource estimate with an effective date of January 21, 2026. 

DXYZ Is The New VCX? As Investors Pile Into New SpaceX Proxy Trade, Here Are Destiny Tech100’s Top Holdings

Databricks is among DXYZ’s holdings expected to pursue an IPO this year, with Saxo noting that the company sits “at the centre of the enterprise data-and-AI stack.”

DXYZ Fund: Investors Race Into New SpaceX Proxy — What’s Inside Destiny Tech100?

This account has been verified as an official VCX representative.

Verified Account

VCXOfficial

Fundrise Innovation Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

Current Price	$113.00
Prev Close	$115.00
Open	$108.00
Dividend Yield	N/A
50-Day Moving Average	$180.51
Beta	0.00
Avg. Volume	817,864.44
PE Ratio	91.87

52-Week High	$575.00
52-Week Low	$31.21
Market Capitalization	$3.2B
EPS (Annual)	$1.23
Price to Book	9.91
Revenue Per Employee	N/A

VCX
Fundrise Innovation Fund

Feed

News

Sentiment

Fundamentals

Info

Latest VCX News

VCXFundrise Innovation Fund